{"id":"double-umbilical-cord-blood-transplant","safety":{"commonSideEffects":[{"rate":null,"effect":"Graft-versus-host disease (GVHD)"},{"rate":null,"effect":"Graft failure or delayed engraftment"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Organ toxicity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This procedure uses stem cells from two separate umbilical cord blood units to overcome the limited cell dose from a single unit, allowing successful engraftment in adult patients. The dual units provide sufficient hematopoietic progenitor cells to restore blood cell production and immune function in patients with hematologic malignancies or bone marrow disorders after myeloablative conditioning.","oneSentence":"Double umbilical cord blood transplant involves infusing two units of umbilical cord blood-derived hematopoietic stem cells to reconstitute the patient's bone marrow and immune system.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:09:53.124Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute leukemia in remission"},{"name":"Chronic leukemia"},{"name":"Myelodysplastic syndrome"},{"name":"Lymphoma"},{"name":"Multiple myeloma"}]},"trialDetails":[{"nctId":"NCT06712108","phase":"","title":"Double Unit Cord Blood Transplant in Hematologic Malignancies.","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2023-12-21","conditions":"Adult Double Unit Cord Blood Transplant","enrollment":40},{"nctId":"NCT05884333","phase":"PHASE2","title":"Cord Blood Transplant in Adults With Blood Cancers","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-05-22","conditions":"Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML)","enrollment":54},{"nctId":"NCT00357565","phase":"PHASE2","title":"Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-11","conditions":"Leukemia, Myelodysplastic Syndromes, Childhood Acute Myeloid Leukemia in Remission","enrollment":34},{"nctId":"NCT06680661","phase":"PHASE2","title":"ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis","status":"RECRUITING","sponsor":"Leland Metheny","startDate":"2025-02-25","conditions":"Acute Myelogenous Leukemia, Acute Lymphatic Leukemia, Chronic Myelogenous Leukemia","enrollment":20},{"nctId":"NCT03434730","phase":"PHASE2","title":"Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-02-07","conditions":"Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Leukemia","enrollment":46},{"nctId":"NCT00719888","phase":"PHASE2","title":"Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2005-11-18","conditions":"Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":135},{"nctId":"NCT00796068","phase":"PHASE2","title":"Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2009-02-24","conditions":"Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission","enrollment":130},{"nctId":"NCT00864227","phase":"PHASE2","title":"Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2008-12","conditions":"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma","enrollment":54},{"nctId":"NCT01586455","phase":"PHASE1","title":"Human Placental-Derived Stem Cell Transplantation","status":"COMPLETED","sponsor":"New York Medical College","startDate":"2013-04","conditions":"Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy","enrollment":43},{"nctId":"NCT01597778","phase":"PHASE3","title":"Double Cord Versus Haploidentical (BMT CTN 1101)","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2012-06","conditions":"Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma","enrollment":368},{"nctId":"NCT01627314","phase":"PHASE2","title":"The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.","status":"TERMINATED","sponsor":"Fate Therapeutics","startDate":"2012-07","conditions":"Hematologic Malignancies","enrollment":62},{"nctId":"NCT00412360","phase":"PHASE3","title":"Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2006-12","conditions":"Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia","enrollment":224},{"nctId":"NCT02298166","phase":"PHASE3","title":"Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations","status":"TERMINATED","sponsor":"University of Ulm","startDate":"2016-11-17","conditions":"Acute Myeloid Leukemia","enrollment":9},{"nctId":"NCT00919503","phase":"PHASE2","title":"Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2009-07-31","conditions":"Non-Neoplastic Hematologic and Lymphocytic Disorder","enrollment":98},{"nctId":"NCT01221857","phase":"PHASE1, PHASE2","title":"Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies","status":"COMPLETED","sponsor":"Gamida Cell ltd","startDate":"2010-11","conditions":"Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS)","enrollment":12},{"nctId":"NCT01690520","phase":"PHASE2","title":"Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"Nohla Therapeutics, Inc.","startDate":"2012-12-11","conditions":"Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission","enrollment":163},{"nctId":"NCT01685411","phase":"NA","title":"Busulfan and Cyclophosphamide Followed By ALLO BMT","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2013-01","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":5},{"nctId":"NCT01300611","phase":"PHASE1","title":"TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation","status":"TERMINATED","sponsor":"Tarix Pharmaceuticals","startDate":"2011-01","conditions":"Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome","enrollment":20},{"nctId":"NCT02991898","phase":"PHASE2","title":"Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2017-02-16","conditions":"Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies","enrollment":3},{"nctId":"NCT00973804","phase":"PHASE1","title":"Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-08-25","conditions":"Leukemia, Non-Hodgkins Lymphoma, Hodgkins Lymphoma","enrollment":4},{"nctId":"NCT00067002","phase":"PHASE2","title":"Randomized Double Cord Blood Transplant Study","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2003-04","conditions":"Leukemia, Lymphocytic, Acute, Leukemia, Myelocytic, Acute, Leukemia, Myeloid, Chronic","enrollment":110},{"nctId":"NCT00801931","phase":"PHASE1, PHASE2","title":"Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders","status":"TERMINATED","sponsor":"Columbia University","startDate":"2007-09-06","conditions":"Leukemia, Lymphoma, Neuroblastoma","enrollment":1},{"nctId":"NCT01175785","phase":"PHASE2","title":"Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies","status":"COMPLETED","sponsor":"Nohla Therapeutics, Inc.","startDate":"2010-08","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities","enrollment":15},{"nctId":"NCT01408563","phase":"PHASE2","title":"Reduced Intensity Double Umbilical Cord Blood Transplantation","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2011-12","conditions":"Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma","enrollment":33},{"nctId":"NCT01093586","phase":"PHASE2","title":"Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2007-09","conditions":"Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7)","enrollment":14},{"nctId":"NCT01745913","phase":"PHASE2","title":"Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2012-10-26","conditions":"Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia","enrollment":2},{"nctId":"NCT01464359","phase":"PHASE2","title":"T-Cell Depleted Double UCB for Refractory AML","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2011-10","conditions":"Acute Myelogenous Leukemia, Refractory Acute Myelogenous Leukemia","enrollment":3},{"nctId":"NCT00871689","phase":"PHASE2","title":"Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2009-01","conditions":"Leukemia","enrollment":2},{"nctId":"NCT00295880","phase":"PHASE1, PHASE2","title":"Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-06","conditions":"Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":12},{"nctId":"NCT00176865","phase":"PHASE2","title":"Stem Cell Transplant for Immunologic or Histiocytic Disorders","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2002-08","conditions":"Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders, Chediak-Higashi Syndrome","enrollment":19},{"nctId":"NCT00686556","phase":"PHASE1","title":"Total Marrow Irradiation for Refractory Acute Leukemia","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2012-08","conditions":"Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Multiple Myeloma","enrollment":12},{"nctId":"NCT00602693","phase":"PHASE1","title":"T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2007-07-23","conditions":"Leukemia, Lymphoma, Multiple Myeloma","enrollment":41},{"nctId":"NCT01163201","phase":"PHASE1, PHASE2","title":"T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies","status":"WITHDRAWN","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2014-01","conditions":"Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia","enrollment":""},{"nctId":"NCT01362452","phase":"PHASE1","title":"Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-12-07","conditions":"Leukemia, Lymphoma","enrollment":5},{"nctId":"NCT00719849","phase":"PHASE2","title":"Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease","status":"TERMINATED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2005-11","conditions":"Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":13},{"nctId":"NCT00763490","phase":"PHASE2","title":"Trial Of Double Umbilical Cord Blood Transplantation","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2008-12","conditions":"Hematological Malignancies","enrollment":20},{"nctId":"NCT01882374","phase":"PHASE2","title":"Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation","status":"WITHDRAWN","sponsor":"Tarix Pharmaceuticals","startDate":"2013-12","conditions":"Hematologic Malignancies","enrollment":""},{"nctId":"NCT01554254","phase":"PHASE2","title":"Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation","status":"WITHDRAWN","sponsor":"Tarix Pharmaceuticals","startDate":"2012-03","conditions":"Cord Blood Transplant, Hematologic Malignancy, Inherited Metabolic Disease","enrollment":""},{"nctId":"NCT01652014","phase":"PHASE2","title":"Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies","status":"WITHDRAWN","sponsor":"University of Medicine and Dentistry of New Jersey","startDate":"2014-01","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission","enrollment":""},{"nctId":"NCT00423826","phase":"","title":"Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease","status":"NO_LONGER_AVAILABLE","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2007-01","conditions":"Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":""},{"nctId":"NCT00597519","phase":"PHASE2","title":"A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2006-03","conditions":"Cancer, Leukemia, Myelodysplastic Syndrome","enrollment":28},{"nctId":"NCT02188290","phase":"","title":"Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation","status":"COMPLETED","sponsor":"Kiadis Pharma","startDate":"2014-09","conditions":"Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome","enrollment":178},{"nctId":"NCT01067300","phase":"PHASE3","title":"A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia Remission","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2010-02","conditions":"Leukemia","enrollment":198},{"nctId":"NCT02385955","phase":"PHASE2","title":"Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2015-04","conditions":"Hematologic Malignancy","enrollment":39},{"nctId":"NCT00343798","phase":"PHASE1","title":"A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2006-04","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission","enrollment":23},{"nctId":"NCT00608517","phase":"NA","title":"Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil","status":"TERMINATED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2005-09","conditions":"Graft Versus Host Disease, Leukemia, Lymphoma","enrollment":6},{"nctId":"NCT00514579","phase":"PHASE2","title":"Adult Double Cord Blood Transplant Study","status":"COMPLETED","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2007-08","conditions":"Cord Blood Stem Cell Transplantation, Hematologic Malignancies","enrollment":56},{"nctId":"NCT01471613","phase":"PHASE1, PHASE2","title":"Lithium, Cord Blood Cells and the Combination in the Treatment of Acute & Sub-acute Spinal Cord Injury","status":"COMPLETED","sponsor":"China Spinal Cord Injury Network","startDate":"2011-09","conditions":"Spinal Cord Injury","enrollment":16},{"nctId":"NCT01983761","phase":"PHASE1, PHASE2","title":"Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation","status":"UNKNOWN","sponsor":"Targazyme, Inc.","startDate":"2013-11","conditions":"Blood And Marrow Transplantation, Leukemia, Lymphoma","enrollment":25},{"nctId":"NCT00890500","phase":"PHASE1","title":"Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.","status":"COMPLETED","sponsor":"Fate Therapeutics","startDate":"2011-01","conditions":"Hematologic Malignancies, Allogeneic Stem Cell Transplantation","enrollment":12},{"nctId":"NCT00393380","phase":"PHASE2","title":"Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor","status":"TERMINATED","sponsor":"The Emmes Company, LLC","startDate":"2006-09","conditions":"Leukemia, Myeloid, Chronic, Anemia, Aplastic, Myelofibrosis","enrollment":13},{"nctId":"NCT00025038","phase":"PHASE2","title":"Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-06","conditions":"Juvenile Myelomonocytic Leukemia","enrollment":100},{"nctId":"NCT01015742","phase":"PHASE2, PHASE3","title":"Unrelated Double Umbilical Cord Blood Units Transplantation","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2009-11","conditions":"Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myeloid, Chronic","enrollment":10},{"nctId":"NCT00881933","phase":"PHASE1, PHASE2","title":"Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)","status":"UNKNOWN","sponsor":"The Korean Society of Pediatric Hematology Oncology","startDate":"2008-11","conditions":"Aplastic Anemia","enrollment":5},{"nctId":"NCT00328237","phase":"PHASE2","title":"Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation","status":"UNKNOWN","sponsor":"Colorado Blood Cancer Institute","startDate":"2005-11","conditions":"Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Double Umbilical Cord Blood Transplant","genericName":"Double Umbilical Cord Blood Transplant","companyName":"Medical College of Wisconsin","companyId":"medical-college-of-wisconsin","modality":"Biologic","firstApprovalDate":"","aiSummary":"Double umbilical cord blood transplant involves infusing two units of umbilical cord blood-derived hematopoietic stem cells to reconstitute the patient's bone marrow and immune system. Used for Acute leukemia in remission, Chronic leukemia, Myelodysplastic syndrome.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}